Wolverine Trading, LLC Vbi Vaccines Inc Transaction History

Wolverine Trading, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$2.8 - $3.72 $55,241 - $73,391	-19,729 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$2.61 - $4.17 $14,154 - $22,613	5,423 Added 37.91%	19,729 $73,000
Q1 2021 May 14, 2021	SELL	$2.91 - $4.32 $17,797 - $26,421	-6,116 Reduced 29.95%	14,306 $42,000
Q4 2020 Feb 12, 2021	BUY	$2.15 - $3.5 $43,907 - $71,477	20,422 New	20,422 $62,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.